Earnings Feed
Start Free
Home/Filings/3/0000950170-25-075934
3//SEC Filing

Atomico IV, L.P. 3

Accession 0000950170-25-075934

CIK 0001673743other
View on SEC.govCompany Profile

Filed

May 20, 8:00 PM ET

Accepted

May 21, 6:41 PM ET

Size

14.7 KB

Accession

0000950170-25-075934

Insider Transaction Report

Form 3
Period: 2025-05-21
Hinge Health, Inc.HNGE
Atomico IV, L.P.
10% Owner
Holdings

  • Series B Preferred Stock

    (indirect: See footnote)
    → Common Stock (2,245,545 underlying)

  • Series D Preferred Stock

    (indirect: See footnote)
    → Common Stock (510,073 underlying)

  • Series A-2 Preferred Stock

    (indirect: See footnote)
    → Common Stock (4,830,917 underlying)

  • Series C Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,175,333 underlying)

  • Series C-1 Preferred Stock

    (indirect: See footnote)
    → Common Stock (602,298 underlying)
Atomico IV (Guernsey), L.P.
10% Owner
Holdings

  • Series A-2 Preferred Stock

    (indirect: See footnote)
    → Common Stock (4,830,917 underlying)

  • Series D Preferred Stock

    (indirect: See footnote)
    → Common Stock (510,073 underlying)

  • Series C-1 Preferred Stock

    (indirect: See footnote)
    → Common Stock (602,298 underlying)

  • Series B Preferred Stock

    (indirect: See footnote)
    → Common Stock (2,245,545 underlying)

  • Series C Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,175,333 underlying)
Atomico Advisors IV, Ltd.
10% Owner
Holdings

  • Series A-2 Preferred Stock

    (indirect: See footnote)
    → Common Stock (4,830,917 underlying)

  • Series C Preferred Stock

    (indirect: See footnote)
    → Common Stock (1,175,333 underlying)

  • Series C-1 Preferred Stock

    (indirect: See footnote)
    → Common Stock (602,298 underlying)

  • Series D Preferred Stock

    (indirect: See footnote)
    → Common Stock (510,073 underlying)

  • Series B Preferred Stock

    (indirect: See footnote)
    → Common Stock (2,245,545 underlying)
Footnotes (7)
  • [F1]Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stockof the Issuer, except for the Series E Preferred Stock, will automatically convert and be reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of newly classified Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation.
  • [F2]Atomico Advisors IV, Ltd. is the general partner of Atomico IV L.P. ("Atomico IV") and Atomico IV (Guernsey), L.P. ("Atomico IV (Guernsey)"). As a result, Atomico Advisors IV, Ltd. may be deemed to have beneficial ownership of the shares held by each of Atomico IV and Atomico IV (Guernsey).
  • [F3]Consists of (i) 3,941,353 shares held by Atomico IV and (ii) 889,564 shares held by Atomico IV (Guernsey).
  • [F4]Consists of (i) 1,832,051 shares held by Atomico IV and (ii) 413,494 shares held by Atomico IV (Guernsey).
  • [F5]Consists of (i) 958,908 shares held by Atomico IV and (ii) 216,425 shares held by Atomico IV (Guernsey).
  • [F6]Consists of (i) 491,398 shares held by Atomico IV and (ii) 110,900 shares held by Atomico IV (Guernsey).
  • [F7]Consists of (i) 416,148 shares held by Atomico IV and (ii) 93,925 shares held by Atomico IV (Guernsey).

Documents

1 file

Issuer

Hinge Health, Inc.

CIK 0001673743

→
Entity typeother
IncorporatedCayman Islands

Related Parties

1
  • filerCIK 0001652865

Filing Metadata

Form type
3
Filed
May 20, 8:00 PM ET
Accepted
May 21, 6:41 PM ET
Size
14.7 KB
View on SEC.gov